Implications of the ESMO study findings on the WHO Essential Medicines List

Date 28 September 2014
Event ESMO 2014
Session Availability of anti-neoplastic medicines across Europe: First results of the ESMO-led European Consortium Study
Topics Bioethics, Legal, and Economic Issues
Presenter Andreas Ullrich
Authors A. Ullrich
  • -, World Health Organization, Cancer Control Programme, 1211 - Geneva/CH